The post CVS Sale Of Omnicare Long-Term Care Pharmacy Continues Portfolio Revamp appeared on BitcoinEthereumNews.com. In this photo is CVS Health Corp. signageThe post CVS Sale Of Omnicare Long-Term Care Pharmacy Continues Portfolio Revamp appeared on BitcoinEthereumNews.com. In this photo is CVS Health Corp. signage

CVS Sale Of Omnicare Long-Term Care Pharmacy Continues Portfolio Revamp

2026/05/14 22:10
3분 읽기
이 콘텐츠에 대한 의견이나 우려 사항이 있으시면 [email protected]으로 연락주시기 바랍니다

In this photo is CVS Health Corp. signage on the floor of the New York Stock Exchange (NYSE) in New York, US, on Monday, July 28, 2025. Photographer: Michael Nagle/Bloomberg

© 2025 Bloomberg Finance LP

A bankruptcy court has approved the sale of CVS Health’s underperforming Omnicare long-term care pharmacy network to GenieRx in a deal valued at $250 million.

CVS said the sale to GenieRx followed a “comprehensive sale process” that was approved by the U.S. Bankruptcy Court for the Northern District of Texas. GenieRx, a joint partnership between private investment firm Milrose Capital LLC and health-care investment and management firm Integro Healthcare Services, “will have the opportunity to strengthen” Omnicare’s service, CVS said.

For CVS, the deal is the latest to focus on profitable businesses. The company’s Aetna health insurance unit left the business of selling individual coverage under the Affordable Care Act known as Obamacare and the company has scaled back opening senior health clinics in favor or smaller drugstore formats.

“We are entering this next phase with clarity on what matters most: delivering reliable pharmacy services, maintaining safe and clinically appropriate care, and being transparent and fair in how we operate,” said Omnicare’s president, David Azzolina, in a statement. “Our teams continue to show a deep commitment to our customers, and I am grateful for the work they do every day to support residents in skilled nursing and assisted living settings.”

When CVS purchased Omnicare for more than $12 billion more than a decade ago, the drugstore giant wanted to expand in the growing business of dispensing and managing prescriptions for the booming number of Americans taking specialized drugs. But the deal never really worked out and the business had low growth and was dogged by fraud investigation that cost CVS hundreds of millions of dollars.

The Omnicare sale is expected to close later this year, CVS said.

“GenieRx’s investment in Omnicare is a testament to the strength of their platform and their impressive employee culture and commitment to putting patients and customers first,” said Rowan Farber, CEO of Integro Healthcare Services. “We admire the trust Omnicare has earned with its customers over decades of serving skilled nursing and assisted living partners, and we look forward to working collaboratively with their team to continue building on that strong foundation and legacy. Together, we share a commitment to delivering reliable service, clinical expertise, and continuity of care to the patients and communities who depend on it most.”

Source: https://www.forbes.com/sites/brucejapsen/2026/05/14/cvs-sale-of-omnicare-long-term-care-pharmacy-continues-portfolio-revamp/

시장 기회
Belong 로고
Belong 가격(LONG)
$0.001064
$0.001064$0.001064
-5.75%
USD
Belong (LONG) 실시간 가격 차트
면책 조항: 본 사이트에 재게시된 글들은 공개 플랫폼에서 가져온 것으로 정보 제공 목적으로만 제공됩니다. 이는 반드시 MEXC의 견해를 반영하는 것은 아닙니다. 모든 권리는 원저자에게 있습니다. 제3자의 권리를 침해하는 콘텐츠가 있다고 판단될 경우, [email protected]으로 연락하여 삭제 요청을 해주시기 바랍니다. MEXC는 콘텐츠의 정확성, 완전성 또는 시의적절성에 대해 어떠한 보증도 하지 않으며, 제공된 정보에 기반하여 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다. 본 콘텐츠는 금융, 법률 또는 기타 전문적인 조언을 구성하지 않으며, MEXC의 추천이나 보증으로 간주되어서는 안 됩니다.

No Chart Skills? Still Profit

No Chart Skills? Still ProfitNo Chart Skills? Still Profit

Copy top traders in 3s with auto trading!